Estrogen Receptor Gene Variants Predict Perinatal Mood Disorders

Perinatal mood disorders affect up to 80% of women during pregnancy and postpartum, with serious consequences for both mothers and children. While estrogen fluctuations during this period have long been suspected as a contributing factor, previous research failed to find clear differences in hormone levels between affected and unaffected women.

This longitudinal study tracked 159 Swiss women from late pregnancy through 12 weeks postpartum, collecting genetic samples and measuring mood symptoms at five time points. Researchers analyzed genetic variations in three estrogen receptor genes (ESR1, ESR2, and GPER) that encode receptors responsible for responding to estrogen signals in the brain.

The key finding was that specific genetic variants in the ESR1 gene significantly predicted mood disturbances. Women carrying the CG haplotype showed increased vulnerability to both depression and anxiety symptoms throughout the perinatal period, while those with the TA haplotype were specifically prone to anxiety. These genetic effects persisted even after accounting for actual estrogen levels, suggesting that receptor sensitivity rather than hormone concentrations drives individual vulnerability.

The ESR1 gene encodes estrogen receptor-alpha (ER-α), which is highly expressed in brain regions crucial for emotional regulation, including the hypothalamus and amygdala. This may explain why ER-α variants had stronger effects than variations in other estrogen receptor genes. The findings support the "estrogen sensitivity hypothesis" - that some women are genetically predisposed to experience mood changes in response to hormonal fluctuations, regardless of absolute hormone levels.

These results could eventually inform personalized screening and treatment approaches for perinatal mental health, helping identify high-risk women before symptoms develop and tailoring interventions based on genetic profiles.